Somite AI
PrivateLast Round
Strategic
Aug 20, 2025
Total Funding Raised
$57.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Somite AI is a biotechnology company developing an AI-driven platform, DeltaStem, to improve the production of human cells for therapeutic use in treating diseases like Type 1 Diabetes, orthopedic injuries, and muscular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Somite AI Comparables
Compare Somite AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mogrify | 83% | |
| Insilico Medicine | 69% | |
| Insitro | 68% |
Somite AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 20, 2025 | ||||
| Series A | May 13, 2025 | ||||
| Pre Seed | Sep 3, 2024 | ||||
| Pre Seed | Apr 16, 2024 |
Key People
Founding team and executive leadership
Somite AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Series A |
| SciFi Ventures | Series A |
| Khosla Ventures | Series A |
| TechAviv | Series A, Pre Seed |
| Montage Ventures | Pre Seed |
| Next Coast Ventures | Pre Seed |
| AMD Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Grew 60% QoQ, from 57 to 91 employees.
- Jun 4, 2026
Grew 45% QoQ, from 58 to 84 employees.
Somite AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access